back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-01-05 17:02 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+18,000 vol |
42,000 | |
| Filed 2022-01-05 17:01 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
113,720 | |
| Filed 2021-06-24 12:01 Tx date 2021-06-21 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,350
+3,000 vol $1.45 each |
3,000 | |
| Filed 2021-06-24 12:00 Tx date 2020-02-24 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 16:18 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2021-03-12 16:17 Tx date 2020-02-24 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 16:16 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,500 vol |
101,720 | |
| Filed 2020-09-16 13:07 Tx date 2020-09-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,991
+3,835 vol $0.78 each |
9,485 | |
| Filed 2020-03-27 16:17 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
94,220 | |
| Filed 2020-03-23 17:11 Tx date 2020-03-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,360
+3,210 vol $0.74 each |
8,118 | |
| Filed 2020-03-18 17:41 Tx date 2020-03-17 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,680
+4,000 vol $0.67 each |
5,650 | |
| Filed 2020-03-18 17:40 Tx date 2020-03-17 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$355.00
+500 vol $0.71 each |
1,650 | |
| Filed 2020-03-02 13:35 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,150 | ||
| Filed 2020-02-27 17:09 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,908 | ||
| Filed 2020-02-27 17:05 Tx date 2020-02-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
69,220 |